CASI Pharmaceuticals, Inc. (CASI) Social Stream
CASI PHARMACEUTICALS INC (CASI) Price Targets From Analysts
Use the tables below to see what analysts covering CASI PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 33 months, CASI's average price target has gone up $8.
CASI reports an average of 304.43% for its upside potential over the past 29 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CASI Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 15 months, CASI's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, CASI PHARMACEUTICALS INC's number of analysts covering the stock is greater than 114.37% of them.
- CASI PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 723.03% of all US stocks.
- In the context of all US stocks, CASI PHARMACEUTICALS INC's average analyst price target is higher than 231.03% of them.
- CASI PHARMACEUTICALS INC's variance in analysts' estimates is lower than -820.85% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CASI PHARMACEUTICALS INC are GERN, VERU, and LFVN.
Is CASI a Buy, Hold or Sell? See the POWR Ratings now!